Allocations
Activa Capital has acquired a majority position in Medisys, together with Turenne Santé, the entrepreneur and new CEO Guillaume Bouillot and the management team. Bernard Chevalier, founder, is supporting the operation and remains a shareholder.
Medisys is a software publisher in the home-care field and for institutions specialised in dependent persons.
After nearly 30 years at the head of the company based in Aix-en-Provence and created in 1991, its founder Bernard Chevalier hands over the management to Guillaume Bouillot, a software entrepreneur.
The new management team will build on values that have made the company successful while providing
Amerborgh has sold a part of its stake in fintech company Ohpen to NPM Capital to finance ongoing and future projects, including the arts and culture centre “het HEM” in Zaandam.
The Ohpen SaaS, cloud native core banking platform administers retail investment and savings accounts for banks and other financial institutions.
Rutger Ruigrok, managing director at NPM Capital, says: “The technology sector is an increasingly important focus point in our investment portfolio. Already, we have had Ohpen in sight as one of the most promising technology companies that we have seen in the past few years. We are impressed with
Imandra Inc – creator of the Imandra cloud-native automated reasoning engine – has completed a USD5 million seed investment led by AlbionVC, IQ Capital and LiveOak Venture Partners.
The capital will be used towards further growth in financial services and fast-growing applications of their AI technology to autonomous vehicles, robotics and machine learning. Imandra democratises deep advances in symbolic AI for making algorithms safe, explainable and fair. Imandra’s “Reasoning as a Service” platform makes these techniques widely accessible to those without specialised background in these fields.
Since its founding in 2014, Imandra has pioneered advances in AI for algorithm safety
Healthcare private equity outperformed other asset classes in 2018, with disclosed deal values surging almost 50 per cent to USD63.1 billion, topping last year’s level of USD42.6 billion, and deal count rising to 316 in 2018 from 265 in 2017.
That’s according to Bain & Company’s eighth Global Healthcare Private Equity and Corporate M&A Report, which reveals that strong investment activity across all regions and in sectors such as healthcare IT (HCIT), provider and biopharma included 18 deals greater than USD1 billion each in disclosed deal value, pushing larger assets to levels that are out of reach for most buyers.
“Last
A cross-jurisdictional Carey Olsen team has advised Marsh & McLennan Companies (MMC) on its acquisition of Jardine Lloyd Thompson Group plc for USD5.6 billion in fully diluted equity value.
The acquisition, which was first announced in September 2018, has now completed and advances MMC’s leadership position in insurance and reinsurance brokerage, health and retirement. It also builds on the group’s efforts to expand in faster-growing geographies and market segments and invest in data and analytics.
Working alongside Slaughter and May who were advising MMC as an integrated team with Wachtell, Lipton, Rosen & Katz, Carey Olsen advised on the
Hg Saturn and its investors have agreed to a further circa EUR640 million equity investment in Visma, a provider of business-critical software to private and public enterprises in the Nordic, Benelux and Baltic regions.
The Canada Pension Plan Investment Board (CPPIB) will also make a further investment of circa EUR110 million in Visma as part of this transaction.
Hg is already the majority owner of Visma, having led the original delisting of Visma from the Oslo Stock Exchange in 2006. Hg has been the lead or co-lead investor in Visma for the last 13 years. Cinven, who first invested
Late-stage, venture-backed tech companies significantly outperformed the S&P 500 and Dow Jones Technology Index in the fourth quarter of 2018, according to the SharesPost US Private Growth Index.
The Index, composed of 106 companies, rose 10.9 per cent in the fourth quarter from the third quarter of 2018. The S&P 500 fell 14.3 per cent in the fourth quarter, and the Dow Jones US Technology Index declined 17.9 per cent from the third quarter of 2018.
Preliminary data for the first quarter of 2019 indicate that the SharesPost Index has increased 11 per cent compared to a 4.2 per cent
Private equity firm Shore Capital Partners has held the and final closings of its third institutional healthcare private equity fund, Shore Capital Healthcare Partners Fund III (HC Fund III), and its inaugural food and beverage fund, Shore Capital Food & Beverage Partners Fund I (F&B Fund I).
HC Fund III raised USD293 million, while F&B Fund I raised USD148 million. With these respective closings, Shore now manages a total committed capital base of more than USD1 billion.
HC Fund III surpassed its original target of USD250 million and was substantially oversubscribed. HC Fund III will continue the successful investment
Estera, a global provider of funds, corporate and trust services, has supported Hipgnosis Songs Fund with its first fundraise – significantly exceeding its target in the process.
Hipgnosis Songs Fund is a Guernsey-registered fund investing in songs and musical intellectual property rights trading on the Specialist Fund Segment of the London Stock Exchange (LSE). It was founded by Merck Mercuriadis, the former manager of Beyoncé, Elton John, Morrissey, Iron Maiden and Guns N’ Roses.
Having raised over GBP200 million with its initial fundraising in July 2018, Hipgnosis Songs announced a placing on 12 April, with a target of GBP100 million
Bryan, Garnier & Co has acquired Beringer Finance, a Nordic-focused boutique investment bank with offices in Stockholm, Oslo, Reykjavik and Palo Alto.
Throughout the past 10 years, Beringer Finance has advised on over 140 transactions, building a strong track record in the TMT, IT Services, and Fintech markets. The closing is subject to pending regulatory approvals and other customary closing conditions.
Olivier Garnier, Co-founder and Managing Partner of Bryan, Garnier & Co, says: “Bryan, Garnier & Co is an independent partnership that combines highly experienced, entrepreneur-minded investment banking professionals with the services and expertise of a top-tier investment bank. The
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
